Maggie M Stoecker

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. doi request reprint Histiocytic/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies
    Maggie M Stoecker
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 137:865-70. 2013
  2. doi request reprint Sudden death due to undiagnosed T lymphoblastic leukemia/lymphoma in a 5-year-old boy
    Maggie M Stoecker
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Forensic Med Pathol 33:314-6. 2012
  3. doi request reprint Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review
    Maggie M Stoecker
    Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Arch Pathol Lab Med 136:832-8. 2012

Collaborators

Detail Information

Publications3

  1. doi request reprint Histiocytic/dendritic cell transformation of B-cell neoplasms: pathologic evidence of lineage conversion in differentiated hematolymphoid malignancies
    Maggie M Stoecker
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Arch Pathol Lab Med 137:865-70. 2013
    ..The clinical outcome of secondary H/DS is dismal, as observed in sporadic cases, and the optimal treatment remains to be determined...
  2. doi request reprint Sudden death due to undiagnosed T lymphoblastic leukemia/lymphoma in a 5-year-old boy
    Maggie M Stoecker
    Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA
    Am J Forensic Med Pathol 33:314-6. 2012
    ..This case also highlights the uncommon, although serious, risks associated with acute lymphoblastic leukemia and hyperleukocytosis...
  3. doi request reprint Systemic mastocytosis with associated clonal hematologic nonmast cell lineage disease: a clinicopathologic review
    Maggie M Stoecker
    Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA
    Arch Pathol Lab Med 136:832-8. 2012
    ..Cytoreductive therapies, splenectomy, allogeneic bone marrow transplant, and tyrosine kinase inhibitors, excluding imatinib, may have potential efficacy in the treatment of these diseases...